(Press-News.org) The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has stopped one arm of a three arm multi-center, clinical trial studying treatments for the lung-scarring disease idiopathic pulmonary fibrosis (IPF) for safety concerns. The trial found that people with IPF receiving a currently used triple-drug therapy consisting of prednisone, azathioprine, and N-acetylcysteine (NAC) had worse outcomes than those who received placebos, or inactive substances.
"These findings underscore why treatments must be evaluated in a rigorous manner," said Susan B. Shurin, M.D., acting director of the NHLBI. "This combination therapy is widely used in patients with IPF, but has not previously been studied in direct comparison to a placebo for all three drugs."
The interim results from this study showed that compared to placebo, those assigned to triple therapy had greater mortality (11 percent versus 1 percent), more hospitalizations (29 percent versus 8 percent), and more serious adverse events (31 percent versus 9 percent) and also had no difference in lung function test changes. Participants randomly assigned to the triple- therapy arm also remained on their assigned treatment at a much lower rate (78 percent adherence versus 98 percent adherence).
"Anyone on some combination of these medications with questions or concerns should consult with their health care provider and not simply stop taking the drugs," said Ganesh Raghu, M.D., professor of medicine at the University of Washington, Seattle and a co-chair of this IPF study. "It is important to realize that these results definitively apply only to patients with well-defined IPF and not to people taking a combination of these drugs for other lung diseases or conditions."
The other two study arms, or intervention groups, of this IPF trial comparing NAC alone to placebo alone will continue. In stopping this part of the trial, the NHLBI accepted the recommendation of the Data and Safety Monitoring Board (DSMB) – an independent advisory group of experts in lung disease, biostatistics, medical ethics, and clinical trial design. The DSMB has been monitoring the study since it began.
This study, called PANTHER-IPF (Prednisone, Azathioprine, and N-acetylcysteine: A Study that Evaluates Response in Idiopathic Pulmonary Fibrosis) was designed and conducted by the Idiopathic Pulmonary Fibrosis Clinical Research Network, funded by the NHLBI. The PANTHER-IPF study was designed to evaluate whether this commonly used triple-therapy regimen could slow disease progression and improve lung function in people with moderate IPF.
PANTHER-IPF was the first study in IPF comparing the effectiveness of this combined treatment to a placebo for all three drugs. Each participant had a one in three chance of being randomized to receive the triple drug regimen, NAC alone, or placebo for a period of up to 60 weeks.
"We will continue to analyze the data to try to understand why this particular combination may be detrimental in people with IPF," said Fernando Martinez, M.D., professor of medicine, University of Michigan, Ann Arbor and co-chair of the PANTHER-IPF study. "The results are not explained by any differences between the two groups before the treatments started."
IPF is a progressive and currently incurable disease characterized by the buildup of fibrous scar tissue within the lungs. This accumulation of scar tissue leads to breathing difficulties, coughing, chest pain, and fatigue. Approximately 200,000 people in the United States have IPF. The cause or causes of IPF remain unknown; as a result treatment options remain limited. PANTHER-IPF began enrollment in October 2009.
The study had enrolled 238 of a planned 390 participants prior to the stop announcement. Participants ranged from 48 to 85 years of age, with an average age of 68. The placebo and NAC arms will continue enrolling and following their participants, and this part of the PANTHER-IPF study is expected to be completed by late 2013.
###
In addition to NIH funding, the Cowlin Family Fund at Chicago Community Trust provided financial support for this study. Zambon donated the NAC and matching placebo; the prednisone, azathioprine, and their matching placebos were purchased using study funds.
Find more information about this clinical trial at http://clinicaltrials.gov/ct2/show/NCT00650091
To arrange an interview with an NHLBI spokesperson, please contact the NHLBI Communications Office at 301-496-4236 or nhlbi_news@nhlbi.nih.gov.
Resources:
What is Idiopathic pulmonary fibrosis?
http://www.nhlbi.nih.gov/health/health-topics/topics/ipf/
Idiopathic Pulmonary Fibrosis Clinical Research Network
https://www.ipfnet.org/
Part of the National Institutes of Health, the National Heart, Lung, and Blood Institute (NHLBI) plans, conducts, and supports research related to the causes, prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood diseases; and sleep disorders. The Institute also administers national health education campaigns on women and heart disease, healthy weight for children, and other topics. NHLBI press releases and other materials are available online at http://www.nhlbi.nih.gov.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
Commonly used 3-drug regimen for idiopathic pulmonary fibrosis found harmful
NIH stops one treatment arm of trial; Other two treatments to continue
2011-10-22
ELSE PRESS RELEASES FROM THIS DATE:
Trio of studies support use of PET/CT scans as prostate cancer staging tool
2011-10-22
ROCHESTER, Minn. -- Recent studies have suggested that C-11 choline positron emission tomography/computerized tomography (PET/CT) scans can be utilized as a staging and potentially therapeutic tool in prostate cancer. The results of three studies, released today during a meeting of the North Central Section of the American Urological Association (http://www.ncsaua.org/default.aspx), validate findings in Europe and expand the potential use of C-11 choline PET scans.
One study found that C-11 choline PET/CT scans can be used as a staging tool rather than multiple x-rays, ...
Divorced Children Receive Less Financial Help From Their Parents
2011-10-22
A recent study conducted by Rice University reveals that children of divorced parents typically receive less college financial aid from their parents as compared with children of intact marriages.
The study surveyed 2,400 undergraduate students and was published in SAGE Publications' June 2011 issue of its "Journal of Family Issues."
The study examined whether divorced/separated and remarried parents contribute less in absolute dollars, as a proportion of their income, and as a proportion of their children's financial need, toward their children's college ...
Mayo Clinic study: PSA test valuable in predicting biopsy need, low-risk prostate cancer
2011-10-22
ROCHESTER, Minn. -- The prostate-specific antigen test, commonly known as the PSA test, is valuable in predicting which men should have biopsies and which are likely to be diagnosed with low-risk prostate cancer, a Mayo Clinic study has found. The findings were released today during a meeting of the North Central Section of the American Urological Association (http://www.ncsaua.org/default.aspx) in Rancho Mirage, Calif.
"The decision to use the PSA test is best made by the patient, in consultation with his doctor," says R. Jeffrey Karnes, M.D. (http://www.mayoclinic.org/bio/12463493.html), ...
Study finds no correlation between primary kidney stone treatment and diabetes
2011-10-22
ROCHESTER, Minn. -- A Mayo Clinic study finds no correlation between the use of shock waves to break up kidney stones and the long-term development of diabetes. The study was released Friday during a meeting of the North Central Section of the American Urological Association (http://www.ncsaua.org/default.aspx) in Rancho Mirage, Calif.
"We did not identify a significant correlation between shockwave lithotripsy and the long-term development of diabetes mellitus," says Matthew Gettman, M.D. (http://www.mayoclinic.org/bio/11940808.html), a Mayo Clinic urologist and co-author ...
November 2011 Geology highlights: New research posted Oct. 5
2011-10-22
Boulder, CO, USA - Another packed issue of GEOLOGY, The Geological Society of America's premier journal and the top-most cited geoscience journal in the world (http://www.scimagojr.com/journalrank.php?category=1907) is online in pre-issue publication. Topics include the San Andreas Fault and SAFOD; the 1944 Tonankai earthquake, Japan; Bonin Island beach sands; the fluid properties of ice; fracturing of the Panamanian Isthmus; diatoms from Ocean Drilling Program Site U1304; China's Loess Plateau; deglaciation and climate change in Turkey; an ancient Death Valley landslide; ...
Preventing cancer development inside the cell cycle
2011-10-22
Researchers from the NYU Cancer Institute, an NCI-designated cancer center at NYU Langone Medical Center, have identified a cell cycle-regulated mechanism behind the transformation of normal cells into cancerous cells. The study shows the significant role that protein networks can play in a cell leading to the development of cancer. The study results, published in the October 21 issue of the journal Molecular Cell, suggest that inhibition of the CK1 enzyme may be a new therapeutic target for the treatment of cancer cells formed as a result of a malfunction in the cell's ...
Drunk Driving Accidents More Likely to Occur at Night Says USDOT
2011-10-22
According to the U.S. Department of Transportation, there is a drunk driving accident fatality every 23 minutes -- with most of them occurring between midnight and 3 a.m. In order to address this issue, and keep the roads safe, the agency launched the "Drive Sober or Get Pulled Over" campaign, which is designed to educate the public about the dangers of drunk driving during nighttime hours and remind drivers that law enforcement will vigilantly patrol at night to keep drunk drivers off the road.
"While we have made great strides in reducing drunk driving ...
Heroin Use in Tennessee Increasing
2011-10-22
A recent story in the Tennessean noted that law enforcement in Tennessee is getting ready for an increase of heroin use. The increase, it is suggested, is due to prescription drug users needing a less expensive replacement for their increasingly expensive drugs and dealers' aggressive marketing techniques.
The article quotes Dr. Terry Alley, as saying "What's happened is the people who sell this product have made it appear safer, made it less expensive, and they give you the misconception that it's less harmful if you smoke it." He is an addiction specialist ...
Voyages Jules Verne Launches New Classic Journeys 2011 and 2012 Brochure
2011-10-22
Voyages Jules Verne has announced the launch of its Classic Journeys 2011 and 2012 brochure, featuring a host of travel ideas including tours, cruises, trains, resorts and weekends.
In association with their longstanding overseas partners, Voyages Jules Verne is delighted to present this compendium of travel opportunities by air, boat and rail, including special sightseeing arrangements and many VJV special events. Among the selection of worldwide departures available until late 2012 are three new tours: Norway's 'Journey to the Arctic Circle' to the remote regions of ...
onShore Networks Announces the Winners of Their Non-Profit Giveaway
2011-10-22
onShore Networks, completeIT (R) services, recently announced the winners of the onShore Non-profit Giveaway. Because non-profit organizations give so much to the community, onShore Networks decided to give something back.
Chicago-area non-profit organizations were invited to select an award from a list of technology services provided by onShore Networks. Organizations that registered were encouraged to spread the word to gather votes for their organization. The contest ran for sixteen weeks. After the votes were tallied, onShore Networks awarded free technology services ...
LAST 30 PRESS RELEASES:
Graz University of Technology opens up new avenues in lung cancer research with digital cell twin
Exoplanets are not water worlds
Study shows increasing ‘healthy competition’ between menu options nudges patients towards greener, lower-fat hospital food choices
New insights into melanoma plasticity uncover a critical role of iron metabolism
A graphene sandwich — deposited or transferred?
New light-powered motor fits inside a strand of hair
Oil rig study reveals vital role of tiny hoverflies
Children’s Hospital of Philadelphia researchers boost widespread use of dental varnish across pediatric network
iRECODE: A new computational method that brings clarity to single-cell analysis
New NUS-MOH study: Singapore’s healthcare sector carbon emissions 18% lower than expected, a milestone in the city-state’s net zero journey
QUT scientists create material to turn waste heat into clean power
Major new report sets out how to tackle the ‘profound and lasting impact’ of COVID-19 on cardiovascular health
Cosmic crime scene: White dwarf found devouring Pluto-like icy world
Major report tackles Covid’s cardiovascular crisis head-on
A third of licensed GPs in England not working in NHS general practice
ChatGPT “thought on the fly” when put through Ancient Greek maths puzzle
Engineers uncover why tiny particles form clusters in turbulent air
GLP-1RA drugs dramatically reduce death and cardiovascular risk in psoriasis patients
Psoriasis linked to increased risk of vision-threatening eye disease, study finds
Reprogramming obesity: New drug from Italian biotech aims to treat the underlying causes of obesity
Type 2 diabetes may accelerate development of multiple chronic diseases, particularly in the early stages, UK Biobank study suggests
Resistance training may improve nerve health, slow aging process, study shows
Common and inexpensive medicine halves the risk of recurrence in patients with colorectal cancer
SwRI-built instruments to monitor, provide advanced warning of space weather events
Breakthrough advances sodium-based battery design
New targeted radiation therapy shows near-complete response in rare sarcoma patients
Does physical frailty contribute to dementia?
Soccer headers and brain health: Study finds changes within folds of the brain
Decoding plants’ language of light
UNC Greensboro study finds ticks carrying Lyme disease moving into western NC
[Press-News.org] Commonly used 3-drug regimen for idiopathic pulmonary fibrosis found harmfulNIH stops one treatment arm of trial; Other two treatments to continue